Always putting healthier
lives first
scroll
News
-
Sawai Group Reports First Half of Quarter FY2022 Financial Results
-
Sawai Group Reports First Quarter FY2022 Financial Results
-
Sawai Group Reports FY2021 Financial Results
-
Sawai Group Reports Third Quarter FY2021 Financial Results
-
Posted the Supplementary Document Associated with Conclusion of Asset Transfer (Acquisition) Agreement
-
Upsher-Smith Launches Dicyclomine Hydrochloride Tablets
-
Sawai Receives Approvals for Three Generic Drugs with 10 Strengths
-
Upsher-Smith Expands Fluoxetine Product Line to Include an Oral Solution
-
Sawai Announces Listing of Six Generic Drugs with 12 Strengths
-
Sawai Receives Approvals for Six Generic Drugs with 13 Strengths
Company Information
